KLRS
Price
$8.60
Change
-$0.54 (-5.91%)
Updated
Feb 4, 02:50 PM (EDT)
Capitalization
172.25M
Intraday BUY SELL Signals
PGEN
Price
$4.54
Change
-$0.27 (-5.62%)
Updated
Feb 4, 03:10 PM (EDT)
Capitalization
1.7B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KLRS vs PGEN

Header iconKLRS vs PGEN Comparison
Open Charts KLRS vs PGENBanner chart's image
Kalaris Therapeutics
Price$8.60
Change-$0.54 (-5.91%)
Volume$2.25K
Capitalization172.25M
Precigen
Price$4.54
Change-$0.27 (-5.62%)
Volume$800
Capitalization1.7B
KLRS vs PGEN Comparison Chart in %
KLRS
Daily Signal:
Gain/Loss:
PGEN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KLRS vs. PGEN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLRS is a Hold and PGEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (KLRS: $9.14 vs. PGEN: $4.80)
Brand notoriety: KLRS and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLRS: 45% vs. PGEN: 62%
Market capitalization -- KLRS: $172.25M vs. PGEN: $1.7B
KLRS [@Biotechnology] is valued at $172.25M. PGEN’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLRS’s FA Score shows that 1 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • KLRS’s FA Score: 1 green, 4 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, KLRS is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLRS’s TA Score shows that 2 TA indicator(s) are bullish while PGEN’s TA Score has 4 bullish TA indicator(s).

  • KLRS’s TA Score: 2 bullish, 3 bearish.
  • PGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than KLRS.

Price Growth

KLRS (@Biotechnology) experienced а -4.89% price change this week, while PGEN (@Biotechnology) price change was +1.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

PGEN is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($1.7B) has a higher market cap than KLRS($172M). PGEN YTD gains are higher at: 14.833 vs. KLRS (8.294). PGEN has more cash in the bank: 121M vs. KLRS (77M). KLRS has less debt than PGEN: KLRS (1.55M) vs PGEN (98.2M).
KLRSPGENKLRS / PGEN
Capitalization172M1.7B10%
EBITDAN/A-243.32M-
Gain YTD8.29414.83356%
P/E RatioN/AN/A-
RevenueN/A6.31M-
Total Cash77M121M64%
Total Debt1.55M98.2M2%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KLRSPGEN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KLRS
Daily Signal:
Gain/Loss:
PGEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VPKIX18.880.24
+1.29%
Vanguard Pacific Stock Index Instl
EITVX46.140.25
+0.54%
Eaton Vance Tx-Mgd Value I
DESRX26.20-0.18
-0.68%
DWS Enhanced Core Equity R
AGIRX21.19-0.16
-0.75%
Alger Mid Cap Growth Institutional R
FSGRX22.90-0.33
-1.42%
Franklin Small Cap Growth A

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with PTHS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
+0.33%
PTHS - KLRS
43%
Loosely correlated
-7.67%
MNOV - KLRS
23%
Poorly correlated
-1.20%
RIGL - KLRS
22%
Poorly correlated
+0.53%
PGEN - KLRS
22%
Poorly correlated
-0.62%
SPRO - KLRS
21%
Poorly correlated
-4.04%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-0.62%
CLDX - PGEN
43%
Loosely correlated
+2.07%
KPTI - PGEN
40%
Loosely correlated
+3.80%
ARRY - PGEN
39%
Loosely correlated
+1.71%
VCYT - PGEN
39%
Loosely correlated
-1.10%
AXON - PGEN
38%
Loosely correlated
-1.89%
More